MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.
about
Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic AcidsBone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic ComplicationsMicroRNAs; easy and potent targets in optimizing therapeutic methods in reparative angiogenesisEpigenetic mechanisms underlying cardiac degeneration and regenerationReactive oxygen species adversely impacts bone marrow microenvironment in diabetesRoles of MicroRNA across Prenatal and Postnatal PeriodsExploring pericyte and cardiac stem cell secretome unveils new tactics for drug discoveryDeveloping miRNA therapeutics for cardiac repair in ischemic heart diseasePrincipal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart diseaseIntegration of Multiple Genomic and Phenotype Data to Infer Novel miRNA-Disease Associations.Emerging role of exosome-mediated intercellular communication in vascular remodelingThe dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsSerum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetesInfluence of statins on distinct circulating microRNAs during prolonged aerobic exercise.Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3High glucose induced oxidative stress and apoptosis in cardiac microvascular endothelial cells are regulated by FoxO3a.Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology.Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in HumansNovel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.MicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAPmiRTarBase 2016: updates to the experimentally validated miRNA-target interactions database.Elevated expressions of serum miR-15a, miR-16, and miR-17-5p are associated with acute ischemic stroke.MicroRNAs in vascular tissue engineering and post-ischemic neovascularizationIncreased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.Circulating micrornas associated with glycemic impairment and progression in Asian IndiansMicroRNAs as pharmacological targets in endothelial cell function and dysfunctionRecurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs.Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia.The non-coding road towards cardiac regeneration.Oxidative stress and microRNAs in vascular diseases.Concise review: MicroRNAs as modulators of stem cells and angiogenesis.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.miRNAs in post-ischaemic angiogenesis and vascular remodelling.MicroRNAs in myocardial infarction.Circulating microRNAs and diabetes: potential applications in medical practice.miRNA-15a/16: as tumor suppressors and more.Biological Response Modifier in Cancer Immunotherapy.Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy.
P2860
Q26744516-A9CF5F78-7A0F-410A-A5A3-29A05F8ED63EQ26749552-63B607EC-FC02-4B00-BF59-5D4DC631DAC7Q26785405-A48698B1-68CB-4994-B305-19AE01CF7A41Q26853220-88BA21C1-299D-4AA8-B4E5-EB230A4D386AQ27002524-7A1A64DB-AD14-4D9E-B42B-FEC165EEFDA8Q28070336-88F0580D-7440-4120-8AA7-6373EEFDF6B5Q28073078-EA3CC437-3C3C-469A-9726-1CA4817C83E0Q28077986-56C32EFB-7003-4418-ACC6-2CBC895FC8B3Q28395122-B6638612-AF2C-4B7A-930B-CABA72B6AD50Q31043232-3CE332BD-C476-4B60-9DAD-F18613AC798DQ33649005-003B0FB0-183A-4A91-9D99-86547621A189Q33662677-75668B09-377F-448A-8ECC-5CF8A8224825Q33671476-99A5DE99-12E5-4169-BE4F-EDC4FA6DCCA5Q33891452-DFDD874D-00EA-4D1C-9F2C-3DA0204A991FQ34579466-A6AB94BD-04EA-427E-B900-802FA3835026Q35048692-91E912E2-6C50-4539-8C7A-D8453CD099EDQ35112471-48333207-74C5-4A03-AC14-6198DF1EE73DQ35752431-2A87BF77-ECCD-4BCB-85FE-223AE191987CQ35817919-D519333C-CED8-484A-855D-826FB623A51FQ35835942-3D9218BB-9F26-4824-AD30-8DEB542B8243Q36429631-E79EA093-F41C-4A18-AFD5-824C9161055CQ36434925-6E368A70-F25A-4B7D-9D53-3C9E414BD1FFQ36492964-CC7BF83E-AE56-49C4-A0F7-0A989B2907EEQ36506217-008E4DBD-D1C2-48C3-9EAA-E38AAA945DB6Q36527551-68959510-D616-454F-B7BC-639C1E23FA74Q36665167-819AB780-193A-4482-99B6-E8024BFA73EAQ36671801-3C8188B3-03CB-47DD-8656-0B4BF7324354Q37118124-EA5AEC52-FC27-43B3-8F86-5FCC8D4737C4Q37439272-711C1F44-91D2-4723-8D18-AEBF3BA194BDQ37653925-579A052F-9E4D-45D5-8C4E-3326E0035317Q38116760-8DCCA548-21F3-4A4E-8AD6-279FD60D2704Q38131402-1A090840-6479-4610-BDAE-5F49A8F7033CQ38180628-CB96B543-CE28-4748-81FB-E675054F3D56Q38217461-AF2CEF16-5CB8-4192-9B29-2E2C6B76D29FQ38268457-627E73B6-B136-483A-AF7C-1FB8000C834FQ38289373-59431DD9-312B-4C66-8398-FBBE8F96EAEBQ38544077-881A87C6-C1C7-4036-960F-7737C7E8296DQ38564093-A54DB34C-14CD-4BC6-9AE4-A7684FC0575BQ38848213-FC496187-4BB1-43E8-967B-3AD0BDC3A9F3Q38997197-5149501C-83DC-4E23-841E-A092F78BC60D
P2860
MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@ast
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@en
type
label
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@ast
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@en
prefLabel
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@ast
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@en
P2093
P2860
P50
P921
P1433
P1476
MicroRNA-15a and microRNA-16 i ...... s with critical limb ischemia.
@en
P2093
Andrea Caporali
Betty Descamps
Claudia Specchia
Costanza Emanueli
Elena Sangalli
Ezio Faglia
Gianfranco Pintus
Micol Marchetti
Paolo Madeddu
P2860
P304
P356
10.1161/CIRCRESAHA.111.300418
P577
2012-12-11T00:00:00Z